Ticker League

Revenue for Gilead Sciences (GILD) 1990-2026

Latest filings through · Reported

Metric

TTM

$29.7B

YoY change

+2.4%

5Y CAGR

+3.6%

Peak year (FY2015)

$32.6B

Revenue history chart for Gilead Sciences (GILD) from 2016 to 2025

Latest: $29.4B

Revenue growth chart for Gilead Sciences (GILD) from 2016 to 2025

Latest: +2.4%

Revenue history table for Gilead Sciences (GILD) from 1990 to 2025

  • FY2025$29.4B+2.4%
  • FY2024$28.8B+6.0%
  • FY2023$27.1B-0.6%
  • FY2022$27.3B-0.1%
  • FY2021$27.3B+10.6%
  • FY2020$24.7B+10.0%
  • FY2019$22.4B+1.5%
  • FY2018$22.1B-15.2%
  • FY2017$26.1B-14.1%
  • FY2016$30.4B-6.9%
  • FY2015$32.6B+31.1%
  • FY2014$24.9B+122.2%
  • FY2013$11.2B+15.5%
  • FY2012$9.7B+15.7%
  • FY2011$8.39B+5.5%
  • FY2010$7.95B+13.4%
  • FY2009$7.01B+31.4%
  • FY2008$5.34B+26.1%
  • FY2007$4.23B+39.8%
  • FY2006$3.03B+49.2%
  • FY2005$2.03B+53.1%
  • FY2004$1.32B+52.6%
  • FY2003$868M+85.9%
  • FY2002$467M+99.7%
  • FY2001$234M+19.5%
  • FY2000$196M+15.7%
  • FY1999$169M+11.8%
  • FY1998$151M+14.2%
  • FY1997$132M+296.1%
  • FY1996$33.4M+1137.0%
  • FY1995$2.7M-44.9%
  • FY1994$4.9M—
  • FY1992$4.2M+50.0%
  • FY1991$2.8M+115.4%
  • FY1990$1.3M—

Revenue values are taken from Gilead Sciences's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Revenue at Gilead Sciences (GILD)

According to Gilead Sciences's latest reported financial statements, the company's current revenue (TTM) is $29.7B. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

2025's annual revenue for Gilead Sciences (GILD) came in at $29.4B – edged up 2.4% year-over-year.

Over 2020–2025 (5 years), Gilead Sciences revenue expanded at a +3.6% compound annual rate, sustaining 2 straight years of year-over-year growth.

Gilead Sciences revenue declined from $32.6B in 2015 to $29.4B in 2025, a 9.8% drawdown.

$32.6B stands as the all-time-high annual revenue, posted in 2015, against a low of $1.3M during 1990.

Gilead Sciences Revenue by Year

Gilead Sciences Revenue 2025: $29.4B

Gilead Sciences revenue in 2025 was $29.4B, edged up 2.4% from 2024.

Gilead Sciences Revenue 2024: $28.8B

2024's revenue for Gilead Sciences came in at $28.8B, grew 6.0% from 2023.

Gilead Sciences Revenue 2023: $27.1B

Gilead Sciences posted revenue of $27.1B in 2023, edged down 0.6% below 2022.

Gilead Sciences Revenue 2022: $27.3B

In 2022, Gilead Sciences reported revenue of $27.3B, edged down 0.1% below 2021.

Gilead Sciences Revenue 2021: $27.3B

Gilead Sciences revenue in 2021 was $27.3B.

See more financial history for Gilead Sciences (GILD).

Sector peers by Revenue

Healthcare peers of Gilead Sciences (GILD), ranked by their latest revenue

Frequently asked questions

Trains Profitability

Gilead Sciences (GILD) Key Financials

Charts, filings, and peer comparison for every metric

Operations

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Capital Return

How this company returns cash to shareholders — buybacks, dividends, and stock splits.